Loading
Immune Cells in Cancer / Ferroptosis and Cancer Prognosis · Journal article
Cell Communication and Signaling · September 4, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review proposing that ferroptosis—an iron-dependent form of regulated cell death—operates as a dual-edged axis within the tumor microenvironment, affecting both cancer cell elimination and T-cell fitness. The authors integrate mechanistic concepts across three layers (membrane lipid composition, antioxidant capacity, and microenvironmental pressure) to explain differential ferroptosis thresholds in malignant and cytotoxic T cells, and discuss potential therapeutic approaches, but note that clinical benefit remains unestablished.
Journal article.
Cytotoxic CD8+ T cells and chimeric antigen receptor T cells may be particularly vulnerable to ferroptotic stress due to activation-induced metabolic reprogramming and hostile TME conditions. Ferroptosis can trigger both immunogenic and immunosuppressive mediators that either ignite or stifle antitumor immunity. Differential modulation of ferroptosis in tumor and immune cells could potentially address resistance to immune checkpoint blockade and improve adoptive cell therapy efficacy, although clinical benefit has yet to be established.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and researchers should recognize that ferroptosis induction strategies require careful optimization to spare T-cell function; this framework may guide future combination approaches with immunotherapy, but current evidence is mechanistic and the authors explicitly state that clinical translation remains largely experimental.
This is a narrative review integrating mechanistic concepts about ferroptosis in tumors and immune cells; it raises questions about the tumor–immune interface rather than reporting empirical results, and explicitly notes that proposed approaches remain experimental with unestablished clinical benefit.
Clinicians and researchers should recognize that ferroptosis induction strategies require careful optimization to spare T-cell function; this framework may guide future combination approaches with immunotherapy, but current evidence is mechanistic and the authors explicitly state that clinical translation remains largely experimental.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Abstract Background Ferroptosis is an iron-dependent form of regulated cell death, which is manifested by the lethal accumulation of lipid peroxides. While it is considered a promising strategy for the elimination of apoptosis-resistant cancer cells, growing evidence highlights the dual role of ferroptosis within the tumor microenvironment (TME), affecting both cancer and immune cells. Main body This review integrates tumor- and immune-cell ferroptosis within a three-layer framework comprising membrane lipid composition, antioxidant capacity, and microenvironmental pressure. We discuss how these layers interact to establish distinct ferroptosis thresholds across malignant and cytotoxic T-cell compartments. We highlight that cytotoxic CD8 + T cells and chimeric antigen receptor T cells may be particularly vulnerable to ferroptotic stress as a result of activation-induced metabolic reprogramming and the hostile, nutrient-deprived conditions of the TME. Furthermore, we discuss the immunomodulatory consequences of ferroptosis, including immunogenic and immunosuppressive mediators that can either ignite or stifle antitumor immunity. Lastly, we consider potential approaches that may leverage tumor ferroptosis while preserving T-cell function through tumor-directed ferroptosis induction and reinforcement of antioxidant defenses in engineered T cells. Conclusion We propose that the ferroptosis axis may play a role in shaping the tumor–immune interface. Differential modulation of ferroptosis in tumor and immune cells could inform future strategies to address resistance to immune checkpoint blockade and improve the efficacy of adoptive cell therapies, although such approaches remain largely experimental and their clinical benefit has yet to be established.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.